BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 8196298)

  • 1. Sustained expression of TGF-beta 1 underlies development of progressive kidney fibrosis.
    Yamamoto T; Noble NA; Miller DE; Border WA
    Kidney Int; 1994 Mar; 45(3):916-27. PubMed ID: 8196298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated expression of transforming growth factor-beta and proteoglycan production in experimental glomerulonephritis. Possible role in expansion of the mesangial extracellular matrix.
    Okuda S; Languino LR; Ruoslahti E; Border WA
    J Clin Invest; 1990 Aug; 86(2):453-62. PubMed ID: 2200803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynamic expression patterns of transforming growth factor-beta(2) and transforming growth factor-beta receptors in experimental glomerulonephritis.
    Hartner A; Hilgers KF; Bitzer M; Veelken R; Schöcklmann HO
    J Mol Med (Berl); 2003 Jan; 81(1):32-42. PubMed ID: 12545247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thrombospondin-1 is a major activator of TGF-beta in fibrotic renal disease in the rat in vivo.
    Daniel C; Wiede J; Krutzsch HC; Ribeiro SM; Roberts DD; Murphy-Ullrich JE; Hugo C
    Kidney Int; 2004 Feb; 65(2):459-68. PubMed ID: 14717916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protease-activated receptor-2 expression in IgA nephropathy: a potential role in the pathogenesis of interstitial fibrosis.
    Grandaliano G; Pontrelli P; Cerullo G; Monno R; Ranieri E; Ursi M; Loverre A; Gesualdo L; Schena FP
    J Am Soc Nephrol; 2003 Aug; 14(8):2072-83. PubMed ID: 12874461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. L-Arginine supplementation increases mesangial cell injury and subsequent tissue fibrosis in experimental glomerulonephritis.
    Peters H; Border WA; Noble NA
    Kidney Int; 1999 Jun; 55(6):2264-73. PubMed ID: 10354274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transforming growth factor-beta receptors in self-limited vs. chronic progressive nephritis in rats.
    Watanabe T; Yamamoto T; Ikegaya N; Fujigaki Y; Suzuki H; Togawa A; Fukasawa H; Nagase M; Hishida A
    J Pathol; 2002 Nov; 198(3):397-406. PubMed ID: 12375273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transforming growth factor-beta protein and mRNA in glomeruli in normal and diseased human kidneys.
    Yoshioka K; Takemura T; Murakami K; Okada M; Hino S; Miyamoto H; Maki S
    Lab Invest; 1993 Feb; 68(2):154-63. PubMed ID: 8441250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. t-PA promotes glomerular plasmin generation and matrix degradation in experimental glomerulonephritis.
    Haraguchi M; Border WA; Huang Y; Noble NA
    Kidney Int; 2001 Jun; 59(6):2146-55. PubMed ID: 11380816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transforming growth factor-beta production during the development of renal fibrosis in rats with subtotal renal ablation.
    Coimbra TM; Carvalho J; Fattori A; Da Silva CG; Lachat JJ
    Int J Exp Pathol; 1996 Aug; 77(4):167-73. PubMed ID: 8943735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reactive oxygen species mediate high glucose-induced plasminogen activator inhibitor-1 up-regulation in mesangial cells and in diabetic kidney.
    Lee EA; Seo JY; Jiang Z; Yu MR; Kwon MK; Ha H; Lee HB
    Kidney Int; 2005 May; 67(5):1762-71. PubMed ID: 15840023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dietary protein restriction rapidly reduces transforming growth factor beta 1 expression in experimental glomerulonephritis.
    Okuda S; Nakamura T; Yamamoto T; Ruoslahti E; Border WA
    Proc Natl Acad Sci U S A; 1991 Nov; 88(21):9765-9. PubMed ID: 1946401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transforming growth factor-beta 1 induces extracellular matrix formation in glomerulonephritis.
    Border WA; Ruoslahti E
    Cell Differ Dev; 1990 Dec; 32(3):425-31. PubMed ID: 2099240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal extracellular matrix accumulation in acute puromycin aminonucleoside nephrosis in rats.
    Jones CL; Buch S; Post M; McCulloch L; Liu E; Eddy AA
    Am J Pathol; 1992 Dec; 141(6):1381-96. PubMed ID: 1281619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tandem antifibrotic actions of L-arginine supplementation and low protein diet during the repair phase of experimental glomerulonephritis.
    Peters H; Border WA; Noble NA
    Kidney Int; 2000 Mar; 57(3):992-1001. PubMed ID: 10720952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In situ localization of transforming growth factor-beta 1 mRNA in the rat kidney with Masugi nephritis.
    Oguchi S; Yamada S; Oguchi H; Nakane PK
    J Clin Lab Anal; 1994; 8(2):99-104. PubMed ID: 8189329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased glomerular and tubular expression of transforming growth factor-beta1, its type II receptor, and activation of the Smad signaling pathway in the db/db mouse.
    Hong SW; Isono M; Chen S; Iglesias-De La Cruz MC; Han DC; Ziyadeh FN
    Am J Pathol; 2001 May; 158(5):1653-63. PubMed ID: 11337363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostaglandin E1 inhibits collagen expression in anti-thymocyte antibody-induced glomerulonephritis: possible role of TGF beta.
    Schneider A; Thaiss F; Rau HP; Wolf G; Zahner G; Jocks T; Helmchen U; Stahl RA
    Kidney Int; 1996 Jul; 50(1):190-9. PubMed ID: 8807588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decorin, biglycan and their endocytosis receptor in rat renal cortex.
    Schaefer L; Hausser H; Altenburger M; Ugorcakova J; August C; Fisher LW; Schaefer RM; Kresse H
    Kidney Int; 1998 Nov; 54(5):1529-41. PubMed ID: 9844129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of transforming growth factor beta is elevated in human and experimental diabetic nephropathy.
    Yamamoto T; Nakamura T; Noble NA; Ruoslahti E; Border WA
    Proc Natl Acad Sci U S A; 1993 Mar; 90(5):1814-8. PubMed ID: 7680480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.